glp 1 and inflammation reduction Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent Antiinflammatory actions of glucagon-like peptide-1–based

Nonsuicidal self-injury in undergraduate students: a cross-sectional study and association with suicidal behavior

The impact of improved glycaemic control with GLP-1 receptor agonist therapy on diabetic retinopathy

This research may eventually lead to specific probiotic recommendations tailored to GLP-1 users, optimizing both gut and urinary health simultaneously

[DOI] [PMC free article] [PubMed] [Google Scholar] 41.Gullaksen S, et al

This show-stopping move should only be performed if the patient requires additional weight loss or glycemic control and has tolerated the previous dosing steps without any missteps